A probe finds several pharma majors in breach of the law; and in turn they blame the government.
Uttar Pradesh is under the scanner again as that state IAS Association has taken on CM Akhilesh Yadav for the suspension of Durga Shakti Nagpal, who campaigned against the sand mafia
The move is expected to delay the introduction of low-priced medicines in the market.
To strengthen Narendra Modi's efforts to bring victory for the Bharatiya Janata Party in the 2014 Lok Sabha elections, the party has decided to build a team of over one million people to spread the party's message to voters. These supporters, not necessarily party members, will use various methods, including SMS and social media, to reach out to voters.
Companies asked to give data for three batches instead of one; move may lead to significant rise in development cost of generics
Concerns over effective control not addressed in the second revised shareholders' agreement, says DIPP; Sebi opposes commercial cooperation pact
Face NPPA fine for overcharging on anti-asthma drug
Besides opposing the suspension of three medicines, the sector has also questioned the process adopted by the government.
The latest price revision includes mostly cardiovascular drugs, anti-bacterials, anti-herpes, contraceptives and gastrointestinal medicines
Fearing outbreak of epidemics, the ministry is sending a high level team to review the public health measures in the area
FDA inspectors visited the Mohali plant in the process of giving approval to Ranbaxy's application for Valsartan.
Data also show that several other leading domestic pharma companies have recalled their products from the US
The National Pharmaceutical Pricing Authority will soon notify prices of as many as 150 packs of essential medicines in line with the new pharma pricing policy, according to official sources.
In a development that could hasten the entry of the generic version of Gleevec into the US market, Indian drug major Sun Pharma has sued Novartis Pharmaceuticals Corp in the District Court of New Jersey, demanding rights to launch a generic version of the cancer drug before the Novartis patent expires.
Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.
The complaint was lodged by Mumbai-based Express Industry Council of India, which represented major express courier and cargo companies such as DTDC, Aramex India, Blue Dart, DHL Express, GATI and First Flight.
FDA had also issued warning letters to Ranbaxy's Paonta Sahib and Dewas facilities as it found extensive problems and deviations from manufacturing norms.
There may be shortage of drugs till pharmaceutical companies supply new batches with revised MRPs.
Apollo Pharmacy, the country's largest branded drug retail network with over 1,500 outlets, has temporarily suspended sale of medicines manufactured by Ranbaxy Laboratories. It has also stopped further procurement from the company for now.
The 2008 deal agreement contains provisions of arbitration to be held in that country.